Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 02, 2020

SELL
$166.71 - $223.91 $198,384 - $266,452
-1,190 Closed
0 $0
Q3 2019

Oct 02, 2019

SELL
$166.23 - $187.09 $64,829 - $72,965
-390 Reduced 24.68%
1,190 $201,000
Q2 2019

Jul 12, 2019

SELL
$164.61 - $190.37 $152,264 - $176,092
-925 Reduced 36.93%
1,580 $290,000
Q4 2018

Jan 25, 2019

SELL
$151.91 - $192.21 $8,658 - $10,955
-57 Reduced 2.22%
2,505 $415,000
Q3 2018

Oct 17, 2018

SELL
$167.73 - $192.74 $194,566 - $223,578
-1,160 Reduced 31.17%
2,562 $494,000
Q4 2017

Jan 29, 2018

BUY
$137.28 - $155.55 $510,956 - $578,957
3,722
3,722 $588,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Stonebridge Capital Management Inc Portfolio

Follow Stonebridge Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.